312 related articles for article (PubMed ID: 29217369)
1. Influence of the intestinal microbiota on the immunogenicity of oral rotavirus vaccine given to infants in south India.
Parker EPK; Praharaj I; Zekavati A; Lazarus RP; Giri S; Operario DJ; Liu J; Houpt E; Iturriza-Gómara M; Kampmann B; John J; Kang G; Grassly NC
Vaccine; 2018 Jan; 36(2):264-272. PubMed ID: 29217369
[TBL] [Abstract][Full Text] [Related]
2. Impact of maternal antibodies and microbiota development on the immunogenicity of oral rotavirus vaccine in African, Indian, and European infants.
Parker EPK; Bronowski C; Sindhu KNC; Babji S; Benny B; Carmona-Vicente N; Chasweka N; Chinyama E; Cunliffe NA; Dube Q; Giri S; Grassly NC; Gunasekaran A; Howarth D; Immanuel S; Jere KC; Kampmann B; Lowe J; Mandolo J; Praharaj I; Rani BS; Silas S; Srinivasan VK; Turner M; Venugopal S; Verghese VP; Darby AC; Kang G; Iturriza-Gómara M
Nat Commun; 2021 Dec; 12(1):7288. PubMed ID: 34911947
[TBL] [Abstract][Full Text] [Related]
3. Breastfeeding linked to the reduction of both rotavirus shedding and IgA levels after Rotarix® immunization in Mexican infants.
Bautista-Marquez A; Velasquez DE; Esparza-Aguilar M; Luna-Cruz M; Ruiz-Moran T; Sugata K; Jiang B; Parashar U; Patel M; Richardson V
Vaccine; 2016 Oct; 34(44):5284-5289. PubMed ID: 27663670
[TBL] [Abstract][Full Text] [Related]
4. The effect of probiotics and zinc supplementation on the immune response to oral rotavirus vaccine: A randomized, factorial design, placebo-controlled study among Indian infants.
Lazarus RP; John J; Shanmugasundaram E; Rajan AK; Thiagarajan S; Giri S; Babji S; Sarkar R; Kaliappan PS; Venugopal S; Praharaj I; Raman U; Paranjpe M; Grassly NC; Parker EPK; Parashar UD; Tate JE; Fleming JA; Steele AD; Muliyil J; Abraham AM; Kang G
Vaccine; 2018 Jan; 36(2):273-279. PubMed ID: 28874323
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of a three dose and five dose oral human rotavirus vaccine (RIX4414) schedule in south Indian infants.
Kompithra RZ; Paul A; Manoharan D; Babji S; Sarkar R; Mathew LG; Kang G
Vaccine; 2014 Aug; 32 Suppl 1():A129-33. PubMed ID: 25091666
[TBL] [Abstract][Full Text] [Related]
6. Interference of Monovalent, Bivalent, and Trivalent Oral Poliovirus Vaccines on Monovalent Rotavirus Vaccine Immunogenicity in Rural Bangladesh.
Emperador DM; Velasquez DE; Estivariz CF; Lopman B; Jiang B; Parashar U; Anand A; Zaman K
Clin Infect Dis; 2016 Jan; 62(2):150-6. PubMed ID: 26349548
[TBL] [Abstract][Full Text] [Related]
7. Rotavirus vaccine response correlates with the infant gut microbiota composition in Pakistan.
Harris V; Ali A; Fuentes S; Korpela K; Kazi M; Tate J; Parashar U; Wiersinga WJ; Giaquinto C; de Weerth C; de Vos WM
Gut Microbes; 2018 Mar; 9(2):93-101. PubMed ID: 28891751
[TBL] [Abstract][Full Text] [Related]
8. A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children.
Dang DA; Nguyen VT; Vu DT; Nguyen TH; Nguyen DM; Yuhuan W; Baoming J; Nguyen DH; Le TL;
Vaccine; 2012 Apr; 30 Suppl 1():A114-21. PubMed ID: 22520120
[TBL] [Abstract][Full Text] [Related]
9. A randomized, open-labelled, non-inferiority phase 4 clinical trial to evaluate the immunogenicity and safety of the live, attenuated, oral rotavirus vaccine, ROTAVAC® in comparison with a licensed rotavirus vaccine in healthy infants.
Ella R; Babji S; Ciarlet M; Blackwelder WC; Vadrevu KM
Vaccine; 2019 Jul; 37(31):4407-4413. PubMed ID: 31178377
[TBL] [Abstract][Full Text] [Related]
10. The effect of increased inoculum on oral rotavirus vaccine take among infants in Dhaka, Bangladesh: A double-blind, parallel group, randomized, controlled trial.
Lee B; Dickson DM; Alam M; Afreen S; Kader A; Afrin F; Ferdousi T; Damon CF; Gullickson SK; McNeal MM; Bak DM; Tolba M; Carmolli MP; Taniuchi M; Haque R; Kirkpatrick BD
Vaccine; 2020 Jan; 38(1):90-99. PubMed ID: 31607603
[TBL] [Abstract][Full Text] [Related]
11. Influence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines.
Patel M; Steele AD; Parashar UD
Vaccine; 2012 Apr; 30 Suppl 1():A30-5. PubMed ID: 22520134
[TBL] [Abstract][Full Text] [Related]
12. Significant Correlation Between the Infant Gut Microbiome and Rotavirus Vaccine Response in Rural Ghana.
Harris VC; Armah G; Fuentes S; Korpela KE; Parashar U; Victor JC; Tate J; de Weerth C; Giaquinto C; Wiersinga WJ; Lewis KD; de Vos WM
J Infect Dis; 2017 Jan; 215(1):34-41. PubMed ID: 27803175
[TBL] [Abstract][Full Text] [Related]
13. Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine (BRV-TV): Randomized, controlled phase III study in Indian infants.
Saluja T; Palkar S; Misra P; Gupta M; Venugopal P; Sood AK; Dhati RM; Shetty A; Dhaded SM; Agarkhedkar S; Choudhury A; Kumar R; Balasubramanian S; Babji S; Adhikary L; Dupuy M; Chadha SM; Desai F; Kukian D; Patnaik BN; Dhingra MS
Vaccine; 2017 Jun; 35(28):3575-3581. PubMed ID: 28536027
[TBL] [Abstract][Full Text] [Related]
14. Compliance of mothers following recommendations to breastfeed or withhold breast milk during rotavirus vaccination in North India: a randomized clinical trial.
Rongsen-Chandola T; Winje BA; Goyal N; Rathore SS; Mahesh M; Ranjan R; Arya A; Rafiqi FA; Bhandari N; Strand TA
Trials; 2014 Jun; 15():256. PubMed ID: 24976452
[TBL] [Abstract][Full Text] [Related]
15. Antirotavirus IgA seroconversion rates in children who receive concomitant oral poliovirus vaccine: A secondary, pooled analysis of Phase II and III trial data from 33 countries.
Baker JM; Tate JE; Leon J; Haber MJ; Lopman BA
PLoS Med; 2019 Dec; 16(12):e1003005. PubMed ID: 31887139
[TBL] [Abstract][Full Text] [Related]
16. A Phase 4, multicentre, randomized, single-blind clinical trial to evaluate the immunogenicity of the live, attenuated, oral rotavirus vaccine (116E), ROTAVAC®, administered simultaneously with or without the buffering agent in healthy infants in India.
Ella R; Bobba R; Muralidhar S; Babji S; Vadrevu KM; Bhan MK
Hum Vaccin Immunother; 2018 Jul; 14(7):1791-1799. PubMed ID: 29543547
[TBL] [Abstract][Full Text] [Related]
17. Rotavirus shedding following administration of RV3-BB human neonatal rotavirus vaccine.
Cowley D; Boniface K; Bogdanovic-Sakran N; Kirkwood CD; Bines JE
Hum Vaccin Immunother; 2017 Aug; 13(8):1908-1915. PubMed ID: 28481726
[TBL] [Abstract][Full Text] [Related]
18. Prevaccination Rotavirus Serum IgG and IgA Are Associated With Lower Immunogenicity of Live, Oral Human Rotavirus Vaccine in South African Infants.
Moon SS; Groome MJ; Velasquez DE; Parashar UD; Jones S; Koen A; van Niekerk N; Jiang B; Madhi SA
Clin Infect Dis; 2016 Jan; 62(2):157-65. PubMed ID: 26400993
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and safety of the diphtheria, pertussis, tetanus and inactivated poliovirus vaccine when co-administered with the human rotavirus vaccine (Rotarix) in healthy Japanese infants: a phase IV randomized study.
Gillard P; Tamura T; Kuroki H; Morikawa Y; Moerman L; Parra J; Kitamura Y; Mihara K; Okamasa A
Hum Vaccin Immunother; 2019; 15(4):800-808. PubMed ID: 30785851
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and Vietnam.
Shin S; Anh DD; Zaman K; Yunus M; Mai le TP; Thiem VD; Azim T; Victor JC; Dallas MJ; Steele AD; Neuzil KM; Ciarlet M
Vaccine; 2012 Apr; 30 Suppl 1():A106-13. PubMed ID: 22520119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
